Exicure Highlights Recent Achievements and Near-term Strategic Priorities
Provided By GlobeNewswire
Last update: Oct 6, 2025
Burixafor (GPC-100) Phase 2 Trial in Multiple Myeloma Nears Key Readout
Preparing for Expansion into Sickle Cell Disease and Acute Myeloid Leukemia
Read more at globenewswire.com
